The US government has begun to consider some of the legal implications for copyright in connection with the development and deployment of artificial intelligence.
Text mining in action: Learn how Eli Lilly and Georgetown University use Natural Language Processing to analyze relationships between publication volume and drug development success, and make patient care decisions.
Can AI – in the shape of Natural Language Processing – bring value to pharma field’s medical affairs and sales teams? Linguamatics’ Jane Reed investigates.
Navigate the opportunities of AI in life sciences. Stay informed about the latest developments shaping the industry’s future and discover actionable insights.